SC-106
N/A
Report date: 2023/04/23 15:22:45
Base Information
Drug NameSC-106
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Eicosapentaenoic acid
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesScotia
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A